Displaying articles by keyword Ventricular assist device

There are various indications for a mechanical circulatory support (MCS) devices implantation. We report a case of the use of…

Congenital paroxysmal atrial fibrillation in infants is a rare occurrence requiring a high index of suspicion. The majority have a…

Deciding to discuss the above topic is determined due to a number of reasons. Firstly, the currently used ablation techniques…

To overcome numerous contradictions in the knowledge of the blood transportation, a hypothesis was supposed asserting the swirling pattern of…

Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.

UPCOMING ISSUE

Our book in WoS™ Core Collection

We are glad to inform you that the book "Theoretical principles of heart cycle phase analysis" written by researchers from Russian New University has been accepted and indexed in The Book Citation Index in Web of Science™ Core Collection

VIDEO ABOUT CARDIOMETRY

OUR PARTNERS

Russian New University


Your online partner for English language editing, proofreading, medical writing, formatting, design & development and publication support services